Newly synthesized compound, PABA-ursodeoxycholic acid, for evaluation of intestinal bacteria.
D010129:4-Aminobenzoic Acid / Q000378:metabolism* / Q000652:urine; D000581:Amidohydrolases / Q000378:metabolism; D062365:Aminobenzoates / Q000378:metabolism*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003840:Deoxycholic Acid / Q000031:analogs & derivatives*; D004755:Enterobacteriaceae / Q000187:drug effects / Q000378:metabolism*; D007422:Intestines / Q000382:microbiology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D014580:Ursodeoxycholic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D062366:para-Aminobenzoates
D062365:Aminobenzoates; D000900:Anti-Bacterial Agents; D062366:para-Aminobenzoates; D003840:Deoxycholic Acid; C055705:PABA-ursodeoxycholic acid; D014580:Ursodeoxycholic Acid; D000581:Amidohydrolases; C023154:choloylglycine hydrolase; D010129:4-Aminobenzoic Acid